NextGxDx Inc.

Genetic testing is the lynchpin of personalized medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 65,000 unique genetic testing products on the market – representing more than 14,000 distinct, clinically relevant categories of tests – and an average of 10 new products enter the market each day. This rapid growth confounds the process through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, NextGxDx launched as a healthcare technology company dedicated to streamlining the genetic test ordering, payment and management for healthcare providers, laboratories and health insurers. With a leading team of physicians, researchers, data scientists and software engineers, NextGxDx launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. NextGxDx provides comprehensive, intuitive solutions that address the specific challenges faced by stakeholders across the healthcare system. - GeneSource® is a web-based tool for clinicians to identify and select the best test for their patients. It is used by clinicians at 14 of the top 15 academic medical centers and 11 of the top 12 children's hospitals. - GeneConnect® is a hospital-based utilization management platform, reducing the cost of genetic testing for top healthcare institutions by helping to steer their volume to high-quality, low-cost laboratories. - GenePayer® delivers transparency into health insurers’ genetic testing claims to achieve greater cost effectiveness. Built on NextGxDx’s comprehensive database, GenePayer matches raw claims to genetic testing products and categorizes them into clinically relevant groups.